Last week, Health Affairs Blog published In ‘Ensuring Timely Approval of Generic Drugs,’ Safety Must Come First, authored by Aimed Alliance’s Director of Public Policy, Stacey L. Worthy. The blog entry analyzes the Fair Access for Safe and Timely Generics (FAST) Act and highlights the need to preserve patient safety through Risk Evaluation and Mitigation Strategies (REMS), by not requiring forced sales. It discusses how high risk drugs require heightened oversight, refutes the notion that REMS impede the development of generics, and points out that protections are in place to prevent the patenting of REMS from being problematic. To read the blog post in its entirety, head over to Health Affairs Blog here.
Last Updated on April 24, 2020 by Aimed Alliance
